VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cytokine1 who wrote (8722)	4/4/2001 10:17:10 PM
From: scaram(o)uche	Read Replies (1) of 9719

SNPs are very much out of favor. Decent approaches to pharmacogenomics, in the context of MYGN, are not. VGNX.......... Yahoo lists 12/31/00 book at $4.38, cash at $4.29.......... biz.yahoo.com Went public in July at $14. I got all the shares I wanted today at 3 11/16. Press release listing....... variagenics.com There are several interesting projects, partnered and unpartnered. One that interests me....... some cancers are characterized by the absence of a hunk of chromosome. Some of those hunks will be characterized my an allele (heterozygosity) for a gene critical to cell survival under given conditions. The company plans to develop allele-specific drugs. Normal cells will be protected by the activity of the alternative allelic product........ delphion.com I have no concept of whether or not the approach is actually workable, and it's somewhat out of my league. The claim language looks great re. targets, but a distinct absence of drugs that will actually do the job is apparent. Revenues were $1.2M and burn was $2.6M for Q4 2000. Presents tomorrow at BioCentury's Future Leaders in the Biotech Industry Conference. I'd be interested in comments or thoughts. I purchased shares, but that doesn't mean that I've done enough homework.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next